IP Library Granted Patent US 12,064,632
Granted Patent B2
US 12,064,632 · App. 17/818,193 · Granted Aug 20, 2024

Method and device for feedback control of neural stimulation

Inventors: Peter Scott Vallack Single (Artarmon, AU); Dean Michael Karantonis (Artarmon, AU)
Assignee: Saluda Medical Pty Ltd
A61N1/36139A61N1/0551A61N1/36062A61N1/36071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,064,632
App. No.
17/818,193
Granted
Aug 20, 2024
Kind
B2
Abstract

A method of controlling a neural stimulus by use of feedback. The neural stimulus is applied to a neural pathway in order to give rise to an evoked action potential on the neural pathway. The stimulus is defined by at least one stimulus parameter. A neural compound action potential response evoked by the stimulus is measured. From the measured evoked response a feedback variable is derived. A feedback loop is completed by using the feedback variable to control the at least one stimulus parameter value. The feedback loop adaptively compensates for changes in a gain of the feedback loop caused by electrode movement relative to the neural pathway.

Claims (46)

1. A method of controlling a neural stimulus, the method comprising:

applying the neural stimulus to a neural pathway of a patient in order to give rise to an evoked action potential on the neural pathway, the stimulus being defined by at least one stimulus parameter, wherein the stimulus parameter is stimulus current amplitude;

measuring a neural compound action potential response evoked by the stimulus, and deriving from the measured evoked response a feedback variable, wherein the feedback variable is an amplitude measure of the evoked compound action potential (ECAP);

completing a feedback loop by using the feedback variable to control the at least one stimulus parameter value; and

determining an estimate of a characteristic of a current ECAP growth curve from the stimulus current amplitude and the measured ECAP amplitude.

2. The method of claim 1 wherein the characteristic is a slope P of the current ECAP growth curve.

3. The method of claim 2 wherein an estimate P′ of the slope P is determined as P′=(V+K)/I, where V is the measured ECAP amplitude, K is a constant or function which relates P to a stimulus threshold T, and I is the stimulus current amplitude.

4. The method of claim 1 , wherein the characteristic is a stimulus threshold T of the current ECAP growth curve.

5. The method of claim 1 , further comprising adaptively compensating for changes in a gain of the feedback loop caused by electrode movement relative to the neural pathway.

6. The method of claim 5 , wherein the adaptively compensating for changes in the gain of the feedback loop comprises maintaining a corner frequency of the feedback loop at a desired value or within a desired range.

7. The method of claim 6 , wherein the desired value or range of the corner frequency is selected to suitably attenuate low frequency noise such as heartbeat as well as high frequency noise such as electrical amplifier noise.

8. The method of claim 6 , wherein the desired value or range of the corner frequency is selected to bias attenuation of heartbeat and noise while the patient is in a more or most sensitive posture.

9. The method of claim 5 , wherein the adaptively compensating comprises introducing the estimate into the feedback loop.

10. The method of claim 9 wherein the characteristic is a slope P of the current ECAP growth curve, and the introducing comprises scaling an error signal of the feedback loop by 1/P′ where P′ is the estimate of the slope.

11. The method of claim 1 wherein the feedback loop is a first order feedback loop.

12. The method of claim 1 wherein the feedback loop is a second order feedback loop.

13. The method of claim 1 wherein a set point of the feedback loop is configured so as to seek a constant value of ECAP amplitude.

14. The method of claim 1 wherein a set point of the feedback loop is configured so as to seek a target ECAP amplitude which changes over time as defined by a therapy map.

15. A non-transitory computer readable medium for controllably applying a neural stimulus, comprising the following instructions for execution by one or more processors:

computer program code means for applying the neural stimulus to a neural pathway of a patient in order to give rise to an evoked action potential on the neural pathway, the stimulus being applied as defined by at least one stimulus parameter, wherein the stimulus parameter is stimulus current amplitude;

computer program code means for measuring a neural compound action potential response evoked by the stimulus and deriving from the measured evoked response a feedback variable, wherein the feedback variable is an amplitude measure of the evoked compound action potential (ECAP);

computer program code means for completing a feedback loop by using the feedback variable to control the at least one stimulus parameter value; and

computer program code means for determining an estimate of a characteristic of a current ECAP growth curve from the stimulus current amplitude and the measured ECAP amplitude.

16. An implantable device for controllably applying a neural stimulus, the device comprising:

a plurality of electrodes including one or more nominal stimulus electrodes and one or more nominal sense electrodes;

a stimulus source for providing a stimulus to be delivered from the one or more stimulus electrodes to a neural pathway of a patient in order to give rise to an evoked action potential on the neural pathway;

measurement circuitry for recording a neural compound action potential signal sensed at the one or more sense electrodes; and

a control unit configured to:

control application of a neural stimulus as defined by at least one stimulus parameter, wherein the stimulus parameter is stimulus current amplitude;

measure via the measurement circuitry a neural compound action potential response evoked by the stimulus;

determine from the measured evoked response a feedback variable, wherein the feedback variable is an amplitude measure of the evoked compound action potential (ECAP);

complete a feedback loop by using the feedback variable to control the at least one stimulus parameter value; and

determining an estimate of a characteristic of a current ECAP growth curve from the stimulus current amplitude and the measured ECAP amplitude.

17. The implantable device of claim 16 , wherein the characteristic is a slope P of the current ECAP growth curve.

18. The implantable device of claim 17 wherein the control unit is configured to determine an estimate P′ of the slope P as P′=(V+K)/I, where V is the measured ECAP amplitude, K is a constant or function which relates P to a stimulus threshold T, and I is the stimulus current amplitude.

19. The implantable device of claim 16 , wherein the characteristic is a stimulus threshold T of the current ECAP growth curve.

20. The implantable device of claim 16 wherein the control unit is further configured to adaptively compensate for changes in a gain of the feedback loop caused by electrode movement relative to the neural pathway.

21. The implantable device of claim 20 wherein the control unit is configured to adaptively compensate for changes in the gain of the feedback loop by maintaining a corner frequency of the feedback loop at a desired value or within a desired range.

22. The implantable device of claim 21 wherein the desired value or range of the corner frequency is selected to suitably attenuate low frequency noise such as heartbeat as well as high frequency noise such as electrical amplifier noise.

23. The implantable device of claim 21 , wherein the desired value or range of the corner frequency is selected to bias attenuation of heartbeat and noise while the patient is in a more or most sensitive posture.

24. The implantable device of claim 23 , wherein the control unit is configured to adaptively compensate for changes in the gain of the feedback loop by introducing the estimate into the feedback loop.

25. The implantable device of claim 20 wherein the characteristic is a slope P of the current ECAP growth curve, and the control unit is configured to scale an error signal of the feedback loop by 1/P′ where P′ is the estimate of the slope.

26. The implantable device of claim 16 , wherein the feedback loop is a first order feedback loop.

27. The implantable device of claim 16 , wherein the feedback loop is a second order feedback loop.

28. The implantable device of claim 16 , wherein a set point of the feedback loop is configured so as to seek a constant value of ECAP amplitude.

29. The implantable device of claim 16 , wherein a set point of the feedback loop is configured so as to seek a target ECAP amplitude which changes over time as defined by a therapy map.

Assignments (2)
SECURITY INTEREST Recorded Mar 14, 2025
From: SALUDA MEDICAL PTY LTD
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070518/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2023
From: SINGLE, PETER SCOTT VALLACK; KARANTONIS, DEAN MICHAEL
To: SALUDA MEDICAL PTY LTD
Reel/Frame 064520/0362 →
Priority Claims (1)
AU 2014905031 · Dec 11, 2014 · national
Continuity (5)
Continuation 17724652 · Apr 20, 2022
Continuation 17532725 · Nov 22, 2021
Continuation 16669393 · Oct 30, 2019
Continuation 15535008
Related Publication 20230078685A1 · Mar 16, 2023